The prognosis of Pleural Mesothelioma is determined with not one but several factors. The detection of cancer at the early stage usually leads to a favourable prognosis and can have a vast impact on the expectancy of the patient. Mesothelioma, like other forms of cancer, tends to have seriously limited choices of treatment when diagnosed at a later stage and prognosis is even compromised most of the time.
Black lung disease is literally making the miners' lungs black and obtained from constant inhalation of coal dust. The effects of black lung disease are long term and can even cause death. Its reaction to accumulated dust can
appear and even worsen during your exposure or even after the inhalation.
Factors
The general health condition of the patient is the most significant factor that influences the prognosis. Mesothelioma diagnosed at an early stage will be able to go through the treatments easier than those who are older, and those with existing conditions. According to studies, persons aged older than 55 are at a higher risk and are more likely to occur to men than women.
The next consideration would be the extent of the metastasis. If the cancer has not yet metastasized to other parts of the body, patient are likely to have several treatment options that will help increase the person's prognosis. Poor prognosis are likely to be in patients that are experiencing difficulty in breathing, having chest pains, cannot carry out daily tasks, weight loss and high level of LDH (lactate dehydrogenase). These are usually indications that the cancer is already on its later stages.
Prognosis for patients who exhibits these symptoms is usually present from six to twelve months. However, persons who are not having these signs will normally have more than a year.
Ways That May Help Improve Prognosis
Stage I patients with Pleural Mesothelioma can opt for a surgery called extrapleural pneumonectomy. This surgery is only offered to patients that are generally in good health. The surgery will remove the affected lung and the lining of the wall of the chest, pericardium and diaphragm. This approach is highly recommended for patients affected with epithelioid cell plerual mesothelioma.
For those patients on the latter stages with black lung disease, an attempt for pleuroctomy can be performed to help increase prognosis. This medical treatment relieves the pain without having to cure the cause of the suffering since it will control the buildup of fluids in the mesothelium or sac. This does not cure, but it can take the pain away and any pressure on the lung.
Survival Rate
As in other lung diseases, the back lung disease is also bleak and narrow. After the diagnosis, there are cancer patients who live for five years or even more. This is called the five-year-survival rate, and the survival rate for this is about 10%. We still need to find out if there's more since these figures come from five years ago. Since treatment and technology have been continually improving, there are chances to improve the survival rate for patients with Mesothelioma and black lung disease.
There are more compelling stories about survivors that are living, and they are willing to tell their stories. This provides hope for other patients under treatment process. Since prognosis may differ depending on cell types, any patient can always hope for a different and longer life expectancy.
Black lung disease is literally making the miners' lungs black and obtained from constant inhalation of coal dust. The effects of black lung disease are long term and can even cause death. Its reaction to accumulated dust can
appear and even worsen during your exposure or even after the inhalation.
Factors
The general health condition of the patient is the most significant factor that influences the prognosis. Mesothelioma diagnosed at an early stage will be able to go through the treatments easier than those who are older, and those with existing conditions. According to studies, persons aged older than 55 are at a higher risk and are more likely to occur to men than women.
The next consideration would be the extent of the metastasis. If the cancer has not yet metastasized to other parts of the body, patient are likely to have several treatment options that will help increase the person's prognosis. Poor prognosis are likely to be in patients that are experiencing difficulty in breathing, having chest pains, cannot carry out daily tasks, weight loss and high level of LDH (lactate dehydrogenase). These are usually indications that the cancer is already on its later stages.
Prognosis for patients who exhibits these symptoms is usually present from six to twelve months. However, persons who are not having these signs will normally have more than a year.
Ways That May Help Improve Prognosis
Stage I patients with Pleural Mesothelioma can opt for a surgery called extrapleural pneumonectomy. This surgery is only offered to patients that are generally in good health. The surgery will remove the affected lung and the lining of the wall of the chest, pericardium and diaphragm. This approach is highly recommended for patients affected with epithelioid cell plerual mesothelioma.
For those patients on the latter stages with black lung disease, an attempt for pleuroctomy can be performed to help increase prognosis. This medical treatment relieves the pain without having to cure the cause of the suffering since it will control the buildup of fluids in the mesothelium or sac. This does not cure, but it can take the pain away and any pressure on the lung.
Survival Rate
As in other lung diseases, the back lung disease is also bleak and narrow. After the diagnosis, there are cancer patients who live for five years or even more. This is called the five-year-survival rate, and the survival rate for this is about 10%. We still need to find out if there's more since these figures come from five years ago. Since treatment and technology have been continually improving, there are chances to improve the survival rate for patients with Mesothelioma and black lung disease.
There are more compelling stories about survivors that are living, and they are willing to tell their stories. This provides hope for other patients under treatment process. Since prognosis may differ depending on cell types, any patient can always hope for a different and longer life expectancy.
